Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20201121001
TCTR20201121001
Not yet recruiting
未知

Site of intravitreal injection and pain assessments from a randomized clinical trial

Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University0 sites80 target enrollmentNovember 21, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSite of intravitreal injection and pain scoreSite of intravitreal injectionpain

Overview

Phase
未知
Intervention
Not specified
Conditions
Site of intravitreal injection and pain score
Sponsor
Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University
Enrollment
80
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 21, 2020
End Date
June 30, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University

Eligibility Criteria

Inclusion Criteria

  • •Age \> or \= 20 years
  • •Diagnosed with neovascular (wet\-type) age\-related macular degeneration or diabetic macular edema or central retinal vein occlusion
  • •Confirmed with optical coherence tomography (OCT) or fundus fluorescein angiography (FFA) or both
  • •Need for intravitreal bevacizumab injection as the treatment for the first time in out\-patient department or retina clinic, Department of Ophthalmology, KCMH

Exclusion Criteria

  • •Patient with any of the following conditions:
  • •History of intravitreal injection
  • •Contraindicated in intravitreal injection
  • •Abnormality or scar on sclera, episclera or conjunctiva
  • •Ophthalmic disease requiring ophthalmic drop other than lubrication
  • •Intraocular pressure \> or \= 22 mmHg
  • •History of scleritis or episcleritis
  • •History of cranial nerve V abnormality
  • •History of intraocular surgery
  • •History of neovascular glaucoma

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Pain from intraocular injections with ultrathin needles compared to regular needles.intravitreal, intraocular, injection, pain, crossover.intravitreaal, intraoculair, injectie, pijn.
NL-OMON29404Radboud University Nijmegen Medical Centre75
Completed
Phase 4
The effect of two local anaesthetic techniques on pain scores during and after intravitreal injectionRetinal diseaseIntravitreal injectionPeri procedural pain
ACTRN12617000182392Flinders University120
Recruiting
Phase 4
Which Intravitreal Injection Site is less Painful and Less Stress for the PatientPain, anxiety, Intravitreal injectionpain, intravitreal injection location, anxiety
TCTR20210719007Priest Hospital180
Completed
Phase 3
The study for the effect of intravitreous injection of ranibizumab (product name: Lucentis) and subthreshold laser photocoagulation on diabetic macular edemadiabetic macular edema
JPRN-UMIN000017037Jichi Medica University, Saitama Medical Center100
Completed
Phase 2
Intravitreal injection of methotrexate in persistent diabetic macular edemaResistant macular edema in diabetic patients.Distrubtion of retinal layers due to edema
IRCT201610098983N2Guilan University of Medical Sciences,Vice chancellor for research42